|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/26 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 4249512 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23177973.7 |
| Date of filing the European patent application | 2018-03-23 | |
| (97) | Date of publication of the European application | 2023-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-23 |
| (46) | Date of publication of the claims translation | 2025-09-10 |
| (30) | Number | Date | Country code |
| 201762482270 P | 2017-04-06 | US |
| (72) |
HU, Qingyan , US
LIU, Dingjiang , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabilus antikūnų preparatas |
| STABLE ANTIBODY FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 9 | 208.00 EUR |
| 2027-03-23 |